infectious diseases
Lefamulin
Use in Pregnancy and Breastfeeding
Animal reproduction studies withlefamulinshow some risk, and no adequate, well-controlled studies have been done in pregnant women. Alternatives tolefamulinshould be considered in pregnant women until better safety data are available. Females with reproductive potential should use contraception while on therapy and for 2 days after the last dose. Animal lactation studies suggest thatlefamulinconcentrates in breast milk. It is advised that lactating women takinglefamulinpump and discard while takinglefamulinand for 2 days after the last dose. 